GSK (GLAXF) Total Liabilities : $60,789 Mil (As of Mar. 2025)

View and export this data going back to . Start your Free Trial

What is GSK Total Liabilities?

GSK's Total Liabilities for the quarter that ended in Mar. 2025 was $60,789 Mil.

GSK's quarterly Total Liabilities declined from Sep. 2024 ($58,989.42 Mil) to Dec. 2024 ($58,630.85 Mil) but then increased from Dec. 2024 ($58,630.85 Mil) to Mar. 2025 ($60,789.41 Mil).

GSK's annual Total Liabilities declined from Dec. 2022 ($60,962.24 Mil) to Dec. 2023 ($58,493.67 Mil) but then increased from Dec. 2023 ($58,493.67 Mil) to Dec. 2024 ($58,630.85 Mil).

GSK Total Liabilities Historical Data

The historical data trend for GSK's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GSK Total Liabilities Chart

GSK Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

80,138.44

76,809.84

60,962.24

58,493.67

58,630.85

GSK Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Liabilities	Get a 7-Day Free Trial															57,537.48	56,356.23	58,989.42	58,630.85	60,789.41

GSK Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

GSK's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	27429.836	+	(18504.425	+	9165.612
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	2356.511	+	1174.463)
	=	58,631

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	75174.463	-	16543.616
	=	58,631

GSK's Total Liabilities for the quarter that ended in Mar. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	26913.437	+	(21284.238	+	10135.658
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	2416.021	+	1174.463)
	=	60,789

Total Liabilities	=	Total Assets (Q: Mar. 2025 )	-	Total Equity (Q: Mar. 2025 )
	=	78430.233	-	17640.827
	=	60,789

GSK Total Liabilities Related Terms

Thank you for viewing the detailed overview of GSK's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

GSK Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSK PLC (OTCPK:GLAXF) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

GSK:USA GSK1:Mexico GSK N:Mexico GSKl:UK GSK:UK GS70:Germany GS71:Germany GS71:Germany GS71:Germany GS70:Germany GS71:Germany G1SK34:Brazil GSK:Argentina

Address

79 New Oxford Street, London, GBR, WC1A 1DG

Website

https://www.gsk.com

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.